Advertisement

Archives of Virology

, Volume 162, Issue 3, pp 793–798 | Cite as

Targeting the rhesus macaque TRIM5α gene to enhance the susceptibility of CD4+ T cells to HIV-1 infection

  • Xiaoli Wang
  • Qing Yu
  • Yahong Yuan
  • Zhiping Teng
  • Dongsheng Li
  • Yi Zeng
Original Article

Abstract

The host range of human immunodeficiency virus type 1 (HIV-1) is extremely narrow, which has hampered the establishment of non-human primate models for HIV-1 infection. The species-specific innate immune factor tripartite motif 5 alpha (TRIM5α) is a key molecule that confers potent resistance against HIV-1 infection. In this study, we targeted the TRIM5α gene of rhesus macaques (rhTRIM5α) using the transcription activator-like effector nuclease (TALEN) to study the effect on HIV-1 infection. CD4+ T cells were separated from the peripheral blood of rhesus macaques by magnetic cell sorting, and the positive rate was greater than 99%. TALEN plasmids targeting rhTRIM5α were constructed and introduced into CD4+ T cells by electroporation, with a transfection efficiency of approximately 25%. The genome of the targeted cells was extracted, and the target efficiency was analyzed by T7E1 enzyme digestion. After sorting the positive transductants, the TALENs induced rhTRIM5α mutations at a rate of more than 40%. The ability of the HIV-1 virus to infect the targeted cells was demonstrated by ELISA. The results showed that targeting rhTRIM5α enhanced the susceptibility to HIV-1 infection. This finding will pave the way for further establishment of a new rhesus macaque model for HIV-1 studies.

Keywords

Acquire Immune Deficiency Syndrome Spry Domain TALEN Target Acquire Immune Deficiency Syndrome Vaccine Acquire Immune Deficiency Syndrome Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

This study was supported by the Ministry of Science and Technology of China (2013ZX10001-004-002-005) and the Natural Science Foundation of Hubei Provincial Department of Education (Q20162110).

Compliance with ethical standards

Competing interests

The authors declare that they have no competing interests.

Ethical standard statement and informed consent

None.

References

  1. 1.
    Roberts RB, Murray HW, Rubin BY, Masur H (1984) Opportunistic infections and impaired cell-mediated immune responses in patients with the acquired immune deficiency syndrome. Trans Am Clin Climatol Assoc 95:40–51PubMedPubMedCentralGoogle Scholar
  2. 2.
    Isanaka S, Mugusi F, Hawkins C, Spiegelman D, Okuma J, Aboud S, Guerino C, Fawzi WW (2012) Effect of high-dose vs standard-dose multivitamin supplementation at the initiation of HAART on HIV disease progression and mortality in Tanzania: a randomized controlled trial. JAMA 308:1535–1544CrossRefPubMedGoogle Scholar
  3. 3.
    Bhatti AB, Usman M, Kandi V (2016) Current scenario of HIV/AIDS, treatment options, and major challenges with compliance to antiretroviral therapy. Cureus 8:e515PubMedPubMedCentralGoogle Scholar
  4. 4.
    Hentrich M, Maretta L, Chow KU, Bogner JR, Schurmann D, Neuhoff P, Jager H, Reichelt D, Vogel M, Ruhnke M, Oette M, Weiss R, Rockstroh J, Arasteh K, Mitrou P (2006) Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin’s disease: results of a multicenter study. Ann Oncol 17:914–919CrossRefPubMedGoogle Scholar
  5. 5.
    Stephenson KE, D’couto HT, Barouch DH (2016) New concepts in HIV-1 vaccine development. Curr Opin Immunol 41:39–46CrossRefPubMedGoogle Scholar
  6. 6.
    Policicchio BB, Pandrea I, Apetrei C (2016) Animal models for HIV cure research. Front Immunol 7:12CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Henning TR, Mcnicholl JM, Vishwanathan SA, Kersh EN (2015) Macaque models of enhanced susceptibility to HIV. Virol J 12:90CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Jia X, Zhao Q, Xiong Y (2015) HIV suppression by host restriction factors and viral immune evasion. Curr Opin Struct Biol 31:106–114CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J (2004) The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427:848–853CrossRefPubMedGoogle Scholar
  10. 10.
    Sayah DM, Sokolskaja E, Berthoux L, Luban J (2004) Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430:569–573CrossRefPubMedGoogle Scholar
  11. 11.
    Yap MW, Nisole S, Stoye JP (2005) A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction. Curr Biol 15:73–78CrossRefPubMedGoogle Scholar
  12. 12.
    Mussolino C, Alzubi J, Fine EJ, Morbitzer R, Cradick TJ, Lahaye T, Bao G, Cathomen T (2014) TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity. Nucleic Acids Res 42:6762–6773CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Himathongkham S, Luciw PA (1996) Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells. Virology 219:485–488CrossRefPubMedGoogle Scholar
  14. 14.
    Nakayama EE, Shioda T (2015) Impact of TRIM5alpha in vivo. AIDS 29:1733–1743CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Evans DT, Silvestri G (2013) Nonhuman primate models in AIDS research. Curr Opin HIV AIDS 8:255–261PubMedPubMedCentralGoogle Scholar
  16. 16.
    Fennessey CM, Keele BF (2013) Using nonhuman primates to model HIV transmission. Curr Opin HIV AIDS 8:280–287PubMedPubMedCentralGoogle Scholar
  17. 17.
    Friedrich BM, Dziuba N, Li G, Endsley MA, Murray JL, Ferguson MR (2011) Host factors mediating HIV-1 replication. Virus Res 161:101–114CrossRefPubMedGoogle Scholar
  18. 18.
    Sauter D (2014) Counteraction of the multifunctional restriction factor tetherin. Front Microbiol 5:163CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Pyndiah N, Telenti A, Rausell A (2015) Evolutionary genomics and HIV restriction factors. Curr Opin HIV AIDS 10:79–83CrossRefPubMedGoogle Scholar
  20. 20.
    Li C, Guan X, Du T, Jin W, Wu B, Liu Y, Wang P, Hu B, Griffin GE, Shattock RJ, Hu Q (2015) Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9. J Gen Virol 96:2381–2393CrossRefPubMedGoogle Scholar
  21. 21.
    Liu H, Chen Y, Niu Y, Zhang K, Kang Y, Ge W, Liu X, Zhao E, Wang C, Lin S, Jing B, Si C, Lin Q, Chen X, Lin H, Pu X, Wang Y, Qin B, Wang F, Wang H, Si W, Zhou J, Tan T, Li T, Ji S, Xue Z, Luo Y, Cheng L, Zhou Q, Li S, Sun YE, Ji W (2014) TALEN-mediated gene mutagenesis in rhesus and cynomolgus monkeys. Cell Stem Cell 14:323–328CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Ding Y, Li H, Chen LL, Xie K (2016) Recent advances in genome editing using CRISPR/Cas9. Front Plant Sci 7:703PubMedPubMedCentralGoogle Scholar
  23. 23.
    He Z, Proudfoot C, Whitelaw CB, Lillico SG (2016) Comparison of CRISPR/Cas9 and TALENs on editing an integrated EGFP gene in the genome of HEK293FT cells. Springerplus 5:814CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Zhang Y, Huang H, Zhang B, Lin S (2016) TALEN- and CRISPR-enhanced DNA homologous recombination for gene editing in zebrafish. Methods Cell Biol 135:107–120CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 2016

Authors and Affiliations

  1. 1.College of Life Science and BioengineeringBeijing University of TechnologyBeijingPeople’s Republic of China
  2. 2.Hubei Key Laboratory of Embryonic Stem Cell Research, Taihe HospitalHubei University of MedicineShiyanPeople’s Republic of China
  3. 3.Institute of VirologyChinese Academy of Preventive MedicineBeijingPeople’s Republic of China

Personalised recommendations